TK2‑D Treatment Market to Reach New Heights by 2030: Driven by Breakthrough Deoxynucleoside
"Executive Summary Thymidine Kinase-2 Deficiency Treatment Market Market : The global thymidine kinase-2 deficiency treatment market size was valued at USD 1.31 billion in 2024 and is expected to reach USD 3.74 billion by 2032, at a CAGR of 6.10% during the forecast period     The market analysis and insights included in the Thymidine Kinase-2 Deficiency Treatment Market...
0 Comentários 0 Compartilhamentos 94 Visualizações